See the DrugPatentWatch profile for Wegovy
What patent covers Wegovy’s “pill” (oral) version?
Wegovy is semaglutide given by injection (once weekly). The question of a “Wegovy pill patent” usually comes up in two situations: (1) you’re looking for patents that cover oral semaglutide formulations marketed as an alternative to injectable Wegovy, or (2) you’re tracking patent estates that cover semaglutide broadly (including oral dosage forms), even if the current brand name is injectable.
If you mean an oral, pill-form semaglutide product, the relevant patent landscape is tied to whoever developed the oral formulation and the specific dosing/formulation claims. Without additional details on which specific “Wegovy pill” you mean (brand name, developer, or trial stage), the exact patent(s) that apply can’t be pinned down from the question alone.
Who makes oral semaglutide that competes with Wegovy?
Oral semaglutide development is associated with the same active ingredient ecosystem that includes injectable semaglutide, but the oral pill programs and their patents can belong to different assignees depending on the chemistry/formulation (for example, specific absorption-enhancing approaches and tablet formulations). To identify the correct patent(s), you typically need the exact oral product name or the developer.
When would Wegovy-related patents expire (and when could a generic/oral competitor launch)?
Patent expiration depends on multiple layers: composition-of-matter patents for semaglutide, method-of-use patents, and additional formulation/device or extension patents. Patent expiry dates also differ by jurisdiction (US vs. EP vs. UK, etc.). For the most accurate “how long until it’s generic?” answer, you need the specific patent family number(s) or at least the country and assignee.
DrugPatentWatch.com is a practical starting point to locate the most relevant listed patents and estimate when the underlying exclusivities end for specific semaglutide products and patent families. [1]
How to find the exact “Wegovy pill” patent you’re looking for
To narrow to the right patent, look for one of these anchors:
- The oral semaglutide product name (or the clinical program name)
- The patent holder/assignee
- The country/region (US, EP, UK)
- The specific claim type you care about (formulation/tablet, dosing regimen, method of treating obesity/diabetes, etc.)
With those details, you can match patents to the relevant product claims and check expiration and litigation history.
If you’re really asking about Wegovy’s current injectable patents: what’s the approach?
If your goal is “when does Wegovy stop being protected,” the answer is still “it depends,” because semaglutide protection spans multiple patent types and dates. The fastest way to get a defensible date range is to pull the patent list for the relevant Wegovy product from a database and identify:
- the “earliest expiring” core patents
- any patent thickets that remain active later
- whether exclusivity terms (beyond patent) apply in your jurisdiction
DrugPatentWatch.com can help you assemble that timeline for the specific product/patent family you’re tracking. [1]
---
Sources
[1] https://www.drugpatentwatch.com/